Emi Shufman

432 total citations
17 papers, 317 citations indexed

About

Emi Shufman is a scholar working on Psychiatry and Mental health, Cellular and Molecular Neuroscience and Clinical Psychology. According to data from OpenAlex, Emi Shufman has authored 17 papers receiving a total of 317 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Psychiatry and Mental health, 5 papers in Cellular and Molecular Neuroscience and 4 papers in Clinical Psychology. Recurrent topics in Emi Shufman's work include Neurotransmitter Receptor Influence on Behavior (5 papers), Schizophrenia research and treatment (4 papers) and Psychedelics and Drug Studies (3 papers). Emi Shufman is often cited by papers focused on Neurotransmitter Receptor Influence on Behavior (5 papers), Schizophrenia research and treatment (4 papers) and Psychedelics and Drug Studies (3 papers). Emi Shufman collaborates with scholars based in Israel. Emi Shufman's co-authors include Rachel Bar‐Hamburger, Eliezer Witztum, Rimona Durst, Dan Gandacu, Grégory Katz, Y Ginath, Shai Porat, Leon Grunhaus, Moshe Kotler and Richard P. Ebstein and has published in prestigious journals such as Biological Psychiatry, Child Abuse & Neglect and Pharmacology Biochemistry and Behavior.

In The Last Decade

Emi Shufman

17 papers receiving 288 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Emi Shufman Israel	9	94	91	83	82	65	17	317
Helena Vorma Finland	9	146 1.6×	81 0.9×	187 2.3×	100 1.2×	31 0.5×	24	431
Stephen J. Schoenthaler United States	11	37 0.4×	165 1.8×	99 1.2×	51 0.6×	51 0.8×	36	473
Bernardo Garcia de Oliveira Soares Brazil	8	92 1.0×	37 0.4×	152 1.8×	49 0.6×	25 0.4×	14	383
Todd W. Estroff United States	10	94 1.0×	45 0.5×	139 1.7×	103 1.3×	37 0.6×	16	432
A. Carter Pottash United States	11	93 1.0×	120 1.3×	99 1.2×	120 1.5×	35 0.5×	15	388
Charles E. Riordan United States	7	170 1.8×	113 1.2×	144 1.7×	141 1.7×	30 0.5×	11	409
Maria Lidia Gerra Italy	10	42 0.4×	60 0.7×	64 0.8×	76 0.9×	30 0.5×	20	324
Rebecca M. Harley United States	6	84 0.9×	27 0.3×	53 0.6×	106 1.3×	38 0.6×	7	361
Josef Hättenschwiler Switzerland	11	51 0.5×	63 0.7×	62 0.7×	86 1.0×	26 0.4×	24	366
Peter A. DeMaria United States	10	164 1.7×	115 1.3×	32 0.4×	116 1.4×	68 1.0×	20	401

Countries citing papers authored by Emi Shufman

Since Specialization

Citations

This map shows the geographic impact of Emi Shufman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emi Shufman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emi Shufman more than expected).

Fields of papers citing papers by Emi Shufman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emi Shufman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emi Shufman. The network helps show where Emi Shufman may publish in the future.

Co-authorship network of co-authors of Emi Shufman

This figure shows the co-authorship network connecting the top 25 collaborators of Emi Shufman. A scholar is included among the top collaborators of Emi Shufman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emi Shufman. Emi Shufman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Katz, Grégory, et al.. (2011). A comparative study of psychiatric inpatients in a general hospital and a psychiatric hospital in Israel: demographics, psychopathological aspects and drug abuse patterns.. PubMed. 13(6). 329–32. 6 indexed citations

Katz, Grégory, et al.. (2011). A comparative study of Arab and Jewish patients admitted for psychiatric hospitalization in Jerusalem: the demographic, psychopathologic aspects, and the drug abuse comorbidity. Comprehensive Psychiatry. 53(6). 850–853. 8 indexed citations

Ornoy, Asher, et al.. (2010). Neurodevelopmental and psychological assessment of adolescents born to drug-addicted parents: Effects of SES and adoption. Child Abuse & Neglect. 34(5). 354–368. 52 indexed citations

Katz, Grégory, Rimona Durst, Emi Shufman, Rachel Bar‐Hamburger, & Leon Grunhaus. (2009). Cannabis abuse and severity of psychotic and affective disorders in Israeli psychiatric inpatients. Comprehensive Psychiatry. 51(1). 37–41. 16 indexed citations

Katz, Grégory, Rimona Durst, Emi Shufman, Rachel Bar‐Hamburger, & Leon Grunhaus. (2008). Substance abuse in hospitalized psychiatric patients.. PubMed. 10(10). 672–5. 26 indexed citations

Shufman, Emi, A Lerner, & Eliezer Witztum. (2005). [Depersonalization after withdrawal from cannabis usage].. PubMed. 144(4). 249–51, 303. 2 indexed citations

Lerner, Arturo G., et al.. (2002). Risperidone-associated, benign transient visual disturbances in schizophrenic patients with a past history of LSD abuse.. PubMed. 39(1). 57–60. 5 indexed citations

Lerner, Arturo G., et al.. (2002). LSD-induced Hallucinogen Persisting Perception Disorder with depressive features treated with reboxetine: case report.. PubMed. 39(2). 100–3. 9 indexed citations

Lerner, A, et al.. (2001). LSD-induced Hallucinogen Persisting Perception Disorder treated with clonazepam: two case reports.. PubMed. 38(2). 133–6. 14 indexed citations

10.

Shufman, Emi & Eliezer Witztum. (2000). [Cannabis--a drug with dangerous implications for mental health].. PubMed. 138(5). 410–3, 423. 3 indexed citations

11.

Katz, Grégory, et al.. (2000). [Drug abuse among patients requiring psychiatric hospitalization].. PubMed. 138(12). 1015–8, 1088. 4 indexed citations

12.

Kotler, Moshe, et al.. (2000). Confirmation of an excess of the high enzyme activity COMTval allele in heroin addicts in a family-based haplotype relative risk study. American Journal of Medical Genetics. 96(5). 599–603. 67 indexed citations

13.

Shufman, Emi, et al.. (1999). Fenethyllin psychosis: description of two cases.. PubMed. 36(2). 129–31. 5 indexed citations

14.

Shufman, Emi, et al.. (1997). Taste- and odor-reactivity in heroin addicts.. PubMed. 34(4). 290–9. 16 indexed citations

15.

Shufman, Emi, et al.. (1996). Electro-encephalography spectral analysis of heroin addicts compared with abstainers and normal controls.. PubMed. 33(3). 196–206. 14 indexed citations

16.

Shufman, Emi, Shai Porat, Eliezer Witztum, et al.. (1994). The efficacy of naltrexone in preventing reabuse of heroin after detoxification. Biological Psychiatry. 35(12). 935–945. 69 indexed citations

17.

Shufman, Emi, et al.. (1990). Treating Israeli opiate addicts with methadone maintenace vs. clonidine detoxification. Pharmacology Biochemistry and Behavior. 36(2). 437–437. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact